{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T09:13:45Z","timestamp":1768986825956,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007135","name":"University of Tennessee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007135","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.transci.2023.103787","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T12:27:04Z","timestamp":1693312024000},"page":"103787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The effect of mobilizing large numbers of CD34\u00a0+\u00a0cells (super-mobilizers) on the engraftment and survival in patients undergoing autologous stem cell transplantation"],"prefix":"10.1016","volume":"62","author":[{"given":"Jan S.","family":"Moreb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori","family":"Lantos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franklin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Dugan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan P.","family":"Skarbnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia Lamont","family":"Kropf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2023.103787_bib1","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1200\/JCO.2008.20.7209","volume":"27","author":"DiPersio","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2023.103787_bib2","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1182\/blood-2008-08-174946","article-title":"Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma","volume":"113","author":"DiPersio","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.transci.2023.103787_bib3","first-page":"1141","article-title":"Efficacy and safety of plerixafor for hematopoietic stem cell mobilization for autologous transplantation in patients with non\u2011Hodgkin lymphoma and multiple myeloma: A systematic review and meta\u2011analysis","volume":"18","author":"Yang","year":"2019","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.transci.2023.103787_bib4","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jcyt.2015.09.002","article-title":"Hematopoietic progenitor cell mobilization with \"just-in-time\" plerixafor approach is a cost-effective alternative to routine plerixafor use","volume":"17","author":"Veltri","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.transci.2023.103787_bib5","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/bmt.2012.60","article-title":"Growth factor plus preemptive (\u2018just-in-time\u2019) plerixafor successfully mobilizes hematopoietic stem cells in multiple myeloma patients despite prior lenalidomide exposure","volume":"47","author":"Costa","year":"2012","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.transci.2023.103787_bib6","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1111\/trf.13141","article-title":"A nationwide survey of the use of plerixafor in patients with lymphoid malignancies who mobilize poorly demonstrates the predominant use of the \"on-demand\" scheme of administration at French autologous hematopoietic stem cell transplant programs","volume":"55","author":"Chabannon","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2023.103787_bib7","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.bbmt.2018.09.013","article-title":"Collection, cryostorage, transplantation, and disposal of hematopoietic stem cell products","volume":"25","author":"Kriegsmann","year":"2019","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.transci.2023.103787_bib8","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.bbmt.2020.04.030","article-title":"Storage, utilization, and disposal of hematopoietic stem cell products in patients with multiple myeloma","volume":"26","author":"Krummradt","year":"2020","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.transci.2023.103787_bib9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.bmt.1705763","article-title":"Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignancies","volume":"40","author":"Bolwell","year":"2007","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.transci.2023.103787_bib10","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1111\/j.1537-2995.2007.01448.x","article-title":"Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation","volume":"47","author":"Wang","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2023.103787_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.0902-4441.2006.t01-1-EJH2895.x","article-title":"Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation","volume":"78","author":"Klaus","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.transci.2023.103787_bib12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s12253-009-9238-x","article-title":"Correlation between survival and number of mobilized CD34+ cells in patients with multiple myeloma or Waldenstr\u00f6m macroglobulinemia","volume":"16","author":"Kakihana","year":"2010","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.transci.2023.103787_bib13","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1200\/JCO.1989.7.11.1621","article-title":"Effectiveness of high dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still sensitive to conventional dose therapy","volume":"7","author":"Gribben","year":"1989","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.transci.2023.103787_bib14","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12885-016-2311-4","article-title":"High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix)","volume":"21","author":"Schorb","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.transci.2023.103787_bib15","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1089\/152581602321080619","article-title":"Early apoptosis largely accounts for functional impairment of CD34+ cells in frozen-thawed stem cell grafts","volume":"11","author":"De Boer","year":"2002","journal-title":"J Hematother Stem Cell Res"},{"key":"10.1016\/j.transci.2023.103787_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbmt.2013.10.013","article-title":"Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations","volume":"20","author":"Giralt","year":"2014","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.transci.2023.103787_bib17","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.bbmt.2014.05.003","article-title":"Peripheral blood pro-genitor cell mobilization for autologous and allogenic stem celltransplantation; guidelines of the American Society for Blood and Marrow Transplantation","volume":"20","author":"Duong","year":"2014","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.transci.2023.103787_bib18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41409-019-0716-9","article-title":"Agreements and uncertainties in autologous haematopoietic stem cell mobilization and collection. A Spanish consensus document","volume":"55","author":"Bueno","year":"2020","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.transci.2023.103787_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jca.21556","article-title":"Poor peripheral blood stem cell mobilization affects long-term outcomes in multiple myeloma patients undergoing autologous stem cell transplantation","volume":"33","author":"Moreb","year":"2018","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2023.103787_bib20","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/1042819031000067585","article-title":"Poor mobilization of peripheral blood stem cells is a risk factor for worse outcome in lymphoma patients undergoing autologous stem cell transplantation","volume":"44","author":"Gordan","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.transci.2023.103787_bib21","first-page":"838","article-title":"Outcomes of poor peripheral blood stem cell mobilizers with multiple myeloma at the first mobilization: A multicenter retrospective study in Japan","volume":"3","author":"Miyamoto-Nagai","year":"2022","journal-title":"E J Haem"},{"issue":"15","key":"10.1016\/j.transci.2023.103787_bib22","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3390\/cancers15030608","article-title":"Poor mobilizers in lymphoma but not myeloma patients had significantly poorer progression-free survival after autologous stem cell transplantation: results of a large retrospective, single-center observational study","author":"Steiner","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.transci.2023.103787_bib23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41409-017-0051-y","article-title":"Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score","volume":"53","author":"Olivieri","year":"2018","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.transci.2023.103787_bib24","first-page":"244.e1","article-title":"Low-dose cyclophosphamide versus intermediate-high-dose cyclophosphamide versus granulocyte colony-stimulating factor alone for stem cell mobilization in multiple myeloma in the era of novel agents: a multicenter retrospective study","volume":"27","author":"Zannetti","year":"2021","journal-title":"Transpl Cell Ther"},{"key":"10.1016\/j.transci.2023.103787_bib25","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/bjc.2011.329","article-title":"High levels of circulating CD34+ cells at autologous stem cell collection are associated with favourable prognosis in multiple myeloma","volume":"105","author":"Raschle","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.transci.2023.103787_bib26","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/bmt.2009.370","article-title":"Clinical impact and resource utilization after stem cell mobilization failure in patients with multiple myeloma and lymphoma","volume":"45","author":"Gertz","year":"2010","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.transci.2023.103787_bib27","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.bbmt.2009.11.012","article-title":"Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantation","volume":"16","author":"Wuchter","year":"2010","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.transci.2023.103787_bib28","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.bbmt.2010.11.021","article-title":"Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma","volume":"17","author":"Stiff","year":"2011","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.transci.2023.103787_bib29","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/sj.bmt.1702708","article-title":"Predictive factors for long-term engraftment of autologous blood stem cells","volume":"26","author":"Duggan","year":"2000","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.transci.2023.103787_bib30","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1200\/JCO.2000.18.6.1360","article-title":"Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy","volume":"18","author":"Siena","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2023.103787_bib31","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2141.2004.04951.x","article-title":"Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy","volume":"125","author":"Blystad","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2023.103787_bib32","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1365-2141.2004.04837.x","article-title":"Favourable results with a single autologous stem cell transplant following conditioning with busulphan and cyclophosphamide in patients with multiple myeloma","volume":"124","author":"Toor","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2023.103787_bib33","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1111\/j.1537-2995.2009.02202.x","article-title":"Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma","volume":"49","author":"Yoon","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2023.103787_bib34","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/sj.bmt.1704050","article-title":"Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's Lymphoma","volume":"31","author":"Gordan","year":"2003","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.transci.2023.103787_bib35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1182\/blood.V98.3.579","article-title":"Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma and non-Hodgkin lymphoma","volume":"98","author":"Porrata","year":"2001","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.transci.2023.103787_bib36","first-page":"CD010615","article-title":"Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma","volume":"2015","author":"Hartmann","year":"2015","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147305022300191X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147305022300191X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:55:23Z","timestamp":1761468923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147305022300191X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S147305022300191X"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2023.103787","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of mobilizing large numbers of CD34\u00a0+\u00a0cells (super-mobilizers) on the engraftment and survival in patients undergoing autologous stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2023.103787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103787"}}